查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1789902

显影剂市场规模、份额和趋势分析报告：按方式、产品、应用、给药途径、最终用途、地区和细分市场预测，2025 年至 2033 年

Contrast Media Market Size, Share & Trends Analysis Report By Modality, By Product, By Application, By Route Of Administration, By End Use, By Region And Segment Forecasts, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

显影剂市场摘要

2024 年全球显影剂市场规模估计为 67.7 亿美元，预计到 2033 年将达到 138.6 亿美元，2025 年至 2033 年的复合年增长率为 8.33%。显影剂的需求受到医学影像诊断需求的不断增长和慢性病负担的增加所推动。

大量的诊断成像程序（例如超音波和 MRI 扫描）预计将支持市场成长。全球对医学影像的需求不断增长是推动显影剂市场扩张的关键因素。医学影像在各种健康状况的早期发现、准确诊断和有效治疗计划中起着至关重要的作用。每年有数百万患者接受 MRI、 电脑断层扫描和 X 光等诊断程序。根据美国国家医学图书馆于 2023 年 10 月发布的一项研究，光在美国每年就进行约 4,000 万次 MRI 扫描。全球影像检查的增加预计将显着增加对显影剂的需求，造影剂对于在这些测试期间增强身体内部结构的可视化至关重要。

美国以外国家对医学影像的需求也在增加。根据澳洲健康与福利研究所 (AIHW) 2024 年 7 月发布的数据，2022-23 年总合1,020 万澳洲人使用了医疗保险补贴的影像服务，约有 400 万人使用了其他诊断服务。预计这一上升趋势将持续下去，进一步推动全球对影像用造影显影剂的需求成长。

此外，随着诊断影像程序对可视化程度要求的不断提高，碘显影剂的需求也显着增长。多种碘显影剂的收益正在强劲增长，反映出其临床应用的日益普及。例如，拜耳公司预计，Ultavist（一种基于碘溴的X射线显影剂，可用于动脉和静脉注射）在2024年的收入将显着增长。这种产品需求的激增凸显了碘显影剂在放射学领域的应用日益广泛，并将成为全球显影剂市场成长的关键驱动力。

钆显影剂和碘基显影剂之间丰富的分子结构推动了市场成长。这种多样性使得能够根据患者需求和临床要求进行客製化的影像诊断，从而提高诊断的准确性和安全性。例如，钆基显影剂广泛应用于MRI，而碘基显影剂则是CT的首选。持续研发安全性和有效性更高的先进显影剂，进一步推动了肿瘤学、循环系统和神经病学等诊断应用领域的市场扩张。

下表列出了 MRI 和 CT 应用中常用的显影剂及其品牌名称和分子组成。

关键意见领袖（KOL）

公司名称 KOL 成长机会

GE医疗集团药物诊断业务全球研发主管保罗·埃文斯博士表示：“这款锰基造影剂的I期研究结果令人鼓舞，我们期待完成临床开发流程的后续步骤。这是我们旨在改善患者全程治疗显影剂的产品平臺的一部分。”

  • 专注于临床开发

费森尤斯卡比美国公司药品行销高级副总裁兼终止药品短缺联盟董事会主席林赛·托马斯表示：「我们正在竭尽全力加快产品供应，包括空运，以帮助我们的客户应对这一严重的显影剂短缺问题。我们还在积极努力提供更多价格实惠的显影剂，以帮助美国临床医生获得必要的诊断仿製药组合。* 扩大製药组合服务。* 扩大学名药组合服务。

  • 解决供应链短缺问题
  • 对经济实惠替代方案的需求不断增长

GE医疗集团药物诊断首席医疗官Mark Hibberd表示：「此次产品组合的扩展使我们能够为众多欧洲国家的客户提供两款领先的大环化合物——Clariscan（钆特酸）和Pixoscan（钆布醇），从而为他们的放射诊断需求提供更多选择。我们将继续创新并投资于我们的显影剂

  • 利用大环化合物扩展投资组合

目录

第一章调查方法与范围

第二章执行摘要

第三章显影剂市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 显影剂市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章显影剂市场：按模式类型的估计和趋势分析

  • 细分仪表板
  • 全球显影剂市场：按模式类型进行的变化分析
  • 全球显影剂市场规模及趋势分析（依模式类型，2021-2033）
  • 超音波
  • 磁振造影
  • X光/电脑断层扫描

第五章显影剂的估计和趋势分析

  • 细分仪表板
  • 全球显影剂市场产品波动分析
  • 全球显影剂市场规模及趋势分析（依产品，2021-2033）
  • 微气泡
  • 钆基
  • 碘化
  • 钡基

第六章显影剂市场：按应用的估计和趋势分析

  • 细分仪表板
  • 全球显影剂市场波动分析（按应用）
  • 全球显影剂市场规模及趋势分析（按应用，2021-2033）
  • 心血管疾病
  • 神经系统疾病
  • 胃肠道疾病
  • 癌症
  • 肾臟疾病
  • 肌肉骨骼疾病
  • 其他的

第七章显影剂市场：按给药途径的估计和趋势分析

  • 细分仪表板
  • 全球显影剂市场依给药途径分析
  • 全球显影剂市场规模及趋势分析（依管理路线，2021-2033）
  • 静脉
  • 口服途径
  • 直肠途径

第 8 章显影剂设备：依最终用途的估算与趋势分析

  • 细分仪表板
  • 全球显影剂市场最终用途分析
  • 全球显影剂市场规模与趋势分析（依最终用途，2021-2033 年）
  • 医院
    • 2021 年至 2033 年医院市场估计与预测
  • 诊断影像中心
    • 2021 年至 2033 年诊断影像中心市场估计与预测
  • 其他的
    • 2021年至2033年其他市场估计与预测

第九章显影剂市场：区域估计和趋势分析（按产品、方式、应用、给药途径和最终用途）

  • 区域仪表板
  • 2021-2033 年市场规模、预测与趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • Key customers
    • Global Key company market share analysis, 2024
    • Bayer AG
    • GE Healthcare
    • Beijing Beilu Pharmaceutical Co., Ltd.
    • Guerbet
    • Arco Lifesciences（I）Pvt. Ltd.
    • Livealth
    • JB Pharma
    • Blue Jet Healthcare.
    • Bracco Diagnostic, Inc.
    • Fresenius Kabi USA, LLC
    • Voyageur Pharmaceuticals, Ltd
    • Grupo Juste
    • Lantheus Holdings, Inc.
    • iMAX
    • Trivitron Healthcare
    • Jodas Expoim Pvt. Ltd.
  • 热图分析/企业市场分析
  • 2024年企业市场占有率预测分析
  • 其他主要市场公司名单
Product Code: GVR-2-68038-357-7

Contrast Media Market Summary

The global contrast media market size was estimated at USD 6.77 billion in 2024 and is projected to reach USD 13.86 billion by 2033, growing at a CAGR of 8.33% from 2025 to 2033. The demand for contrast media is rising owing to the increasing demand for medical imaging and the growing burden of chronic disorders.

High volume of imaging procedures, such as ultrasound and MRI scans, performed is anticipated to support the market growth. The growing global demand for medical imaging is a key factor driving the expansion of the contrast media market. Medical imaging plays a crucial role in the early detection, accurate diagnosis, and effective treatment planning of various health conditions. Millions of patients undergo diagnostic procedures such as MRI, CT scans, and X-rays every year. According to a study published by the National Library of Medicine in October 2023, approximately 40 million MRI scans are performed annually in the U.S. alone. The increasing volume of imaging procedures worldwide is expected to significantly boost the demand for contrast media, essential for enhancing the visualization of internal body structures during these examinations.

Beyond the U.S., other countries are also experiencing a rising demand for medical imaging procedures. According to data published by the Australian Institute of Health & Welfare (AIHW) in July 2024, a total of 10.2 million Australians accessed Medicare-subsidized diagnostic imaging services in 2022-23, while approximately 4.0 million utilized other diagnostic services. This upward trend is expected to continue in the coming years, further contributing to the growing global demand for contrast media used in diagnostic imaging.

Furthermore, the demand for iodinated contrast media is rising significantly, driven by the growing number of imaging procedures requiring enhanced visualization. Several iodinated contrast agents are experiencing strong revenue growth, reflecting increased clinical adoption. For example, in 2024, Bayer AG reported a notable revenue increase from Ultravist, its iopromide-based X-ray contrast agent used for both intra-arterial and intravenous applications. This surge in product demand underscores the expanding utilization of iodinated contrast media in radiology, positioning them as a critical driver in the growth of the global contrast media market.

The availability of diverse molecular formulations among gadolinium-based and iodinated contrast agents drives market growth. This variety allows for tailored imaging based on patient needs and clinical requirements, enhancing diagnostic accuracy and safety. For instance, gadolinium agents are widely used in MRI applications, while iodinated agents are suitable for CT procedures. Continued R&D into advanced contrast media with improved safety and efficacy further supports market expansion across diagnostic applications like oncology, cardiology, and neurology.

The pictorial representation below highlights commonly used contrast agents in MRI and CT applications, along with their respective brand names and molecular compositions.

Key Opinion Leaders

Company Name KOLs Growth Opportunities

Dr Paul Evans, head of global R&D at GE HealthCare's Pharmaceutical Diagnostics business segment "These are encouraging Phase I results for this manganese-based contrast agent, and we look forward to completing the next steps in the clinical development process. This is part of our pipeline of products aiming to improve patient outcomes across care pathways." * Emerging Manganese-Based Contrast Agents

  • Focus on Clinical Development

Lindsey Thomas, senior vice president of Pharmaceutical Marketing at Fresenius Kabi USA and the company's representative on the End Drug Shortage Alliance Board of Directors "The U.S. availability of Iodixanol Injection, USP is the first offering from our generic radiology portfolio. We are doing everything we can to accelerate product availability to help our customers during this acute contrast media agent shortage, including air shipping product. We are also actively working to bring additional affordable contrast agents to U.S. clinicians to help ensure patient access to essential diagnostic imaging procedures." * Expansion of Generic Radiology Portfolio

  • Addressing Supply Chain Shortages
  • Growing Demand for Affordable Alternatives

Mark Hibberd, Chief Medical Officer, GE HealthCare Pharmaceutical Diagnostics "This extension to our portfolio means we will be able to offer two leading macrocyclic molecules-Clariscan (gadoteric acid) and Pixxoscan (gadobutrol)-to our customers in a number of European countries, offering radiology departments even more choice to suit their diagnostic needs. We continue to innovate and invest in our contrast media portfolio to deliver for healthcare professionals and patients and to meet future demand." * Geographic Market Penetration

  • Portfolio Expansion with Macrocyclic Molecules

Global Contrast Media Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global contrast media market report based on product, modality type, application, route of administration, end use, and region:

  • Modality Outlook (Revenue, USD Million, 2021-2033)
  • Ultrasound
  • Magnetic Resonance Imaging
  • X-ray/Computed Tomography
  • Product Outlook (Revenue, USD Million, 2021-2033)
  • Microbubble
  • Gadolinium-Based
  • Iodinated
  • Barium-Based
  • Application Outlook (Revenue, USD Million, 2021-2033)
  • Cardiovascular Disorders
  • Neurological Disorders
  • Gastrointestinal Disorders
  • Cancer
  • Nephrological Disorders
  • Musculoskeletal Disorders
  • Others
  • Route of Administration Outlook (Revenue, USD Million, 2021-2033)
  • Intravenous
  • Oral Route
  • Rectal Route
  • End Use Outlook (Revenue, USD Million, 2021-2033)
  • Hospitals
  • Diagnostic Imaging Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021-2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Modality
    • 1.1.3. Application
    • 1.1.4. Route Of Administration
    • 1.1.5. End use
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Contrast Media Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for medical imaging
      • 3.2.1.2. Approvals and launches of contrast media agents
      • 3.2.1.3. Increasing disease burden
      • 3.2.1.4. Technological advancements
      • 3.2.1.5. Rising production capacities for contrast media
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Recalls of contrast media
      • 3.2.2.2. Shortage of Iohexol and Iodixanol
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Development of interconnected solutions in contrast agents
      • 3.2.3.2. Growing number of clinical trials
      • 3.2.3.3. Improvements in public and private healthcare infrastructure
      • 3.2.3.4. Growth potential in emerging economies in contrast media market
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Potential complications and risks associated with contrast media
  • 3.3. Contrast Media Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Contrast Media Market: Modality Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Contrast Media Market Modality Type Movement Analysis
  • 4.3. Global Contrast Media Market Size & Trend Analysis, by Modality Type, 2021 to 2033 (USD Million)
  • 4.4. Ultrasound
    • 4.4.1. Ultrasound market estimates and forecasts for 2021 to 2033 (USD Million)
  • 4.5. Magnetic Resonance Imaging
    • 4.5.1. Magnetic resonance imaging market estimates and forecasts for 2021 to 2033 (USD Million)
  • 4.6. X-ray/Computed Tomography
    • 4.6.1. X-ray/computed tomography market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Contrast Media Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Contrast Media Market Product Movement Analysis
  • 5.3. Global Contrast Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 5.4. Microbubble
    • 5.4.1. Microbubble market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.5. Gadolinium-Based
    • 5.5.1. Gadolinium-based market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.6. Iodinated
    • 5.6.1. Iodinated market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.7. Barium-based
    • 5.7.1. Barium-based market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. Contrast Media Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Contrast Media Market Application Movement Analysis
  • 6.3. Global Contrast Media Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Cardiovascular Disorders
    • 6.4.1. Cardiovascular disorders market estimates and forecast 2021 to 2033 (USD Million)
  • 6.5. Neurological Disorders
    • 6.5.1. Neurological disorders market estimates and forecast 2021 to 2033 (USD Million)
  • 6.6. Gastrointestinal Disorders
    • 6.6.1. Gastrointestinal disorders market estimates and forecast 2021 to 2033 (USD Million)
  • 6.7. Cancer
    • 6.7.1. Cancer market estimates and forecast 2021 to 2033 (USD Million)
  • 6.8. Nephrological Disorders
    • 6.8.1. Nephrological disorders market estimates and forecast 2021 to 2033 (USD Million)
  • 6.9. Musculoskeletal Disorders
    • 6.9.1. Musculoskeletal disorders market estimates and forecast 2021 to 2033 (USD Million)
  • 6.10. Others
    • 6.10.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Contrast Media Market: Route of Administration Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Contrast Media Market Route Of Administration Movement Analysis
  • 7.3. Global Contrast Media Market Size & Trend Analysis, by Route Of Administration, 2021 to 2033 (USD Million)
  • 7.4. Intravenous
    • 7.4.1. Intravenous market estimates and forecast 2021 to 2033 (USD Million)
  • 7.5. Oral Route
    • 7.5.1. Oral route market estimates and forecast 2021 to 2033 (USD Million)
  • 7.6. Rectal Route
    • 7.6.1. Rectal route market estimates and forecast 2021 to 2033 (USD Million)

Chapter 8. Contrast Media Devices: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Contrast Media Market End Use Movement Analysis
  • 8.3. Global Contrast Media Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 8.4. Hospitals
    • 8.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
  • 8.5. Diagnostic Imaging Centers
    • 8.5.1. Diagnostic imaging centers market estimates and forecasts for 2021 to 2033 (USD Million)
  • 8.6. Others
    • 8.6.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 9. Contrast Media Market: Regional Estimates & Trend Analysis By Product, By Modality, By Application, By Route of Administration, By End Use

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 9.3. North America
    • 9.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Competitive scenario
      • 9.3.2.3. Regulatory framework
      • 9.3.2.4. Reimbursement scenario
      • 9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
    • 9.3.3. Canada
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Competitive scenario
      • 9.3.3.3. Regulatory framework
      • 9.3.3.4. Reimbursement scenario
      • 9.3.3.5. Canada market estimates and forecasts, 2021 - 2033
    • 9.3.4. Mexico
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. Competitive scenario
      • 9.3.4.3. Regulatory framework
      • 9.3.4.4. Reimbursement scenario
      • 9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Competitive scenario
      • 9.4.1.3. Regulatory framework
      • 9.4.1.4. Reimbursement scenario
      • 9.4.1.5. UK market estimates and forecasts, 2021 - 2033
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Competitive scenario
      • 9.4.2.3. Regulatory framework
      • 9.4.2.4. Reimbursement scenario
      • 9.4.2.5. Germany market estimates and forecasts, 2021 - 2033
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Competitive scenario
      • 9.4.3.3. Regulatory framework
      • 9.4.3.4. Reimbursement scenario
      • 9.4.3.5. France market estimates and forecasts, 2021 - 2033
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Competitive scenario
      • 9.4.4.3. Regulatory framework
      • 9.4.4.4. Reimbursement scenario
      • 9.4.4.5. Italy market estimates and forecasts, 2021 - 2033
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Competitive scenario
      • 9.4.5.3. Regulatory framework
      • 9.4.5.4. Reimbursement scenario
      • 9.4.5.5. Spain market estimates and forecasts, 2021 - 2033
    • 9.4.6. Denmark
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Competitive scenario
      • 9.4.6.3. Regulatory framework
      • 9.4.6.4. Reimbursement scenario
      • 9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Competitive scenario
      • 9.4.7.3. Regulatory framework
      • 9.4.7.4. Reimbursement scenario
      • 9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
    • 9.4.8. Norway
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Competitive scenario
      • 9.4.8.3. Regulatory framework
      • 9.4.8.4. Reimbursement scenario
      • 9.4.8.5. Norway market estimates and forecasts, 2021 - 2033
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Competitive scenario
      • 9.5.1.3. Regulatory framework
      • 9.5.1.4. Reimbursement scenario
      • 9.5.1.5. Japan market estimates and forecasts, 2021 - 2033
    • 9.5.2. India
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Competitive scenario
      • 9.5.2.3. Regulatory framework
      • 9.5.2.4. Reimbursement scenario
      • 9.5.2.5. India market estimates and forecasts, 2021 - 2033
    • 9.5.3. China
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Competitive scenario
      • 9.5.3.3. Regulatory framework
      • 9.5.3.4. Reimbursement scenario
      • 9.5.3.5. China market estimates and forecasts, 2021 - 2033
    • 9.5.4. South Korea
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Competitive scenario
      • 9.5.4.3. Regulatory framework
      • 9.5.4.4. Reimbursement scenario
      • 9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
    • 9.5.5. Australia
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Competitive scenario
      • 9.5.5.3. Regulatory framework
      • 9.5.5.4. Reimbursement scenario
      • 9.5.5.5. Australia market estimates and forecasts, 2021 - 2033
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Competitive scenario
      • 9.5.6.3. Regulatory framework
      • 9.5.6.4. Reimbursement scenario
      • 9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Competitive scenario
      • 9.6.1.3. Regulatory framework
      • 9.6.1.4. Reimbursement scenario
      • 9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Competitive scenario
      • 9.6.2.3. Regulatory framework
      • 9.6.2.4. Reimbursement scenario
      • 9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Competitive scenario
      • 9.7.1.3. Regulatory framework
      • 9.7.1.4. Reimbursement scenario
      • 9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Competitive scenario
      • 9.7.2.3. Regulatory framework
      • 9.7.2.4. Reimbursement scenario
      • 9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Competitive scenario
      • 9.7.3.3. Regulatory framework
      • 9.7.3.4. Reimbursement scenario
      • 9.7.3.5. UAE market estimates and forecasts, 2021 - 2033
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Competitive scenario
      • 9.7.4.3. Regulatory framework
      • 9.7.4.4. Reimbursement scenario
      • 9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
    • 10.2.1. Innovators
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Global Key company market share analysis, 2024
    • 10.3.4. Bayer AG
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. GE Healthcare
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Beijing Beilu Pharmaceutical Co., Ltd.
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Guerbet
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Arco Lifesciences (I) Pvt. Ltd.
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Livealth
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. JB Pharma
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Blue Jet Healthcare.
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Product benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Bracco Diagnostic, Inc.
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Product benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. Fresenius Kabi USA, LLC
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Product benchmarking
      • 10.3.13.4. Strategic initiatives
    • 10.3.14. Voyageur Pharmaceuticals, Ltd
      • 10.3.14.1. Company overview
      • 10.3.14.2. Financial performance
      • 10.3.14.3. Product benchmarking
      • 10.3.14.4. Strategic initiatives
    • 10.3.15. Grupo Juste
      • 10.3.15.1. Company overview
      • 10.3.15.2. Financial performance
      • 10.3.15.3. Product benchmarking
      • 10.3.15.4. Strategic initiatives
    • 10.3.16. Lantheus Holdings, Inc.
      • 10.3.16.1. Company overview
      • 10.3.16.2. Financial performance
      • 10.3.16.3. Product benchmarking
      • 10.3.16.4. Strategic initiatives
    • 10.3.17. iMAX
      • 10.3.17.1. Company overview
      • 10.3.17.2. Financial performance
      • 10.3.17.3. Product benchmarking
      • 10.3.17.4. Strategic initiatives
    • 10.3.18. Trivitron Healthcare
      • 10.3.18.1. Company overview
      • 10.3.18.2. Financial performance
      • 10.3.18.3. Product benchmarking
      • 10.3.18.4. Strategic initiatives
    • 10.3.19. Jodas Expoim Pvt. Ltd.
      • 10.3.19.1. Company overview
      • 10.3.19.2. Financial performance
      • 10.3.19.3. Product benchmarking
      • 10.3.19.4. Strategic initiatives
  • 10.4. Heat Map Analysis/ Company Market Position Analysis
  • 10.5. Estimated Company Market Share Analysis, 2024
  • 10.6. List of Other Key Market Players

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America contrast media market, by country, 2021 - 2033 (USD Million)
  • Table 4. North America contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 5. North America contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 6. North America contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 7. North America contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 8. North America contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 9. U.S. contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 10. U.S. contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 11. U.S. contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 12. U.S. contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 13. U.S. contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 14. Canada contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 15. Canada contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 16. Canada contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 17. Canada contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 18. Canada contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 19. Mexico contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 20. Mexico contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 21. Mexico contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 22. Mexico contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 23. Mexico contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 24. Europe contrast media market, by country, 2021 - 2033 (USD Million)
  • Table 25. Europe contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 26. Europe contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 27. Europe contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 28. Europe contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 29. Europe contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 30. UK contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 31. UK contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 32. UK contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 33. UK contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 34. UK contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 35. Germany contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 36. Germany contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 37. Germany contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 38. Germany contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 39. Germany contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 40. France contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 41. France contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 42. France contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 43. France contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 44. France contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 45. Italy contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 46. Italy contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 47. Italy contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 48. Italy contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 49. Italy contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 50. Spain contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 51. Spain contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 52. Spain contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 53. Spain contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 54. Spain contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 55. Denmark contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 56. Denmark contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 57. Denmark contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 58. Denmark contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 59. Denmark contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 60. Sweden contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 61. Sweden contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 62. Sweden contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 63. Sweden contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 64. Sweden contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 65. Norway contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 66. Norway contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 67. Norway contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 68. Norway contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 69. Norway contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 70. Asia Pacific contrast media market, by country, 2021 - 2033 (USD Million)
  • Table 71. Asia Pacific contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 72. Asia Pacific contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 73. Asia Pacific contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 74. Asia Pacific contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 75. Asia Pacific contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 76. China contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 77. China contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 78. China contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 79. China contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 80. China contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 81. Japan contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 82. Japan contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 83. Japan contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 84. Japan contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 85. Japan contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 86. India contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 87. India contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 88. India contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 89. India contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 90. India contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 91. South Korea contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 92. South Korea contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 93. South Korea contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 94. South Korea contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 95. South Korea contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 96. Australia contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 97. Australia contrast media market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 98. Australia contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 99. Australia contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 100. Australia contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 101. Thailand contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 102. Thailand contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 103. Thailand contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 104. Thailand contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 105. Thailand contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 106. Latin America contrast media market, by country, 2021 - 2033 (USD Million)
  • Table 107. Latin America contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 108. Latin America contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 109. Latin America contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 110. Latin America contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 111. Latin America contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 112. Brazil contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 113. Brazil contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 114. Brazil contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 115. Brazil contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 116. Brazil contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 117. Argentina contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 118. Argentina contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 119. Argentina contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 120. Argentina contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 121. Argentina contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 122. Middle East & Africa contrast media market, by country, 2021 - 2033 (USD Million)
  • Table 123. Middle East & Africa contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 124. Middle East & Africa contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 125. Middle East & Africa contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 126. Middle East & Africa contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 127. Middle East & Africa contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 128. South Africa contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 129. South Africa contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 130. South Africa contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 131. South Africa contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 132. South Africa contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 133. Saudi Arabia contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 134. Saudi Arabia contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 135. Saudi Arabia contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 136. Saudi Arabia contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 137. Saudi Arabia contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 138. UAE contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 139. UAE contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 140. UAE contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 141. UAE contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 142. UAE contrast media market, by application, 2021 - 2033 (USD Million)
  • Table 143. Kuwait contrast media market, by product, 2021 - 2033 (USD Million)
  • Table 144. Kuwait contrast media market, by route of administration, 2021 - 2033 (USD Million)
  • Table 145. Kuwait contrast media market, by modality type, 2021 - 2033 (USD Million)
  • Table 146. Kuwait contrast media market, by end use, 2021 - 2033 (USD Million)
  • Table 147. Kuwait contrast media market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Contrast Media Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Contrast media market: Modality movement analysis
  • Fig. 15 Ultrasound Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Magnetic Resonance Imaging Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 17 X-Ray/Computed Tomography Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Contrast Media Market: Product Movement Analysis
  • Fig. 19 Microbubble Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Gadolinium-Based Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Iodinated Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Barium-Based Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Contrast Media Market: Application Movement Analysis
  • Fig. 24 Cardiovascular Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Neurological Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Cancer Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Gastrointestinal Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Nephrological Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Musculoskeletal Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Gastrointestinal Disorders Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Contrast Media Market: Route Of Administration Movement Analysis
  • Fig. 32 Intravenous Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Oral Route Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Rectal Route Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Contrast Media Market: End Use Movement Analysis
  • Fig. 36 Hospitals Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Diagnostic Imaging Centers Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Regional Outlook, 2024 & 2033
  • Fig. 40 North America Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 42 Canada Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 43 Mexico Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 44 Europe Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 45 Germany Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 46 UK Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 47 France Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 48 Italy Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 50 Denmark Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 51 Sweden Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 52 Norway Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 55 China Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 56 India Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 57 Australia Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 58 South Korea Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 59 Thailand Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 60 Latin America Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 61 Brazil Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 62 Argentina Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 63 Middle East and Africa Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 64 South Africa Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 65 Saudi Arabia Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 66 UAE Contrast Media Market, 2021 - 2033 (USD Million)
  • Fig. 67 Kuwait Contrast Media Market, 2021 - 2033 (USD Million)